VIVOJECT
LIVE

Serial Number

98820324

Owner

Revvity Health Sciences, Inc.

Attorney

Kevin A. Oliver

First Use Date

Feb 12, 2025

Filing Date

Oct 25, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VIVOJECT Trademark

Serial Number: 98820324

VIVOJECT is a trademark filed by Revvity Health Sciences, Inc. on October 25, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Revvity Health Sciences, Inc.

77 4th Avenue
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

October 25, 2024

Registration Date

Not Registered

First Use Anywhere

February 12, 2025

First Use in Commerce

February 12, 2025

Published for Opposition

October 21, 2025

Goods & Services

Drug delivery devices sold empty, namely, injection instruments with needles; Medical devices and apparatus, namely, medical guidewires and parts and fittings therefor; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Injection instruments with needles

Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in disease modeling in pharmaceutical research; Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in targeted drug delivery in pharmaceutical research; Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in gene therapy research in pharmaceutical research; Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in cell therapy research in pharmaceutical research; Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in cardiovascular pharmaceutical research; Medical laboratory research instruments for injection of cells and drugs into organs and tissue for use in neurological pharmaceutical research; Medical laboratory research instruments that deliver cells into organs and tissue for use with in vivo imaging devices; Medical laboratory research instruments that deliver therapeutic agents into organs and tissue for use with in vivo imaging devices; Medical laboratory research instruments that deliver drugs into organs and tissue for use with in vivo imaging devices; Ultrasound inspection devices for non-medical, non-destructive testing; Medical laboratory research instruments for ultrasound systems, namely, ultrasound probes, not for medical use; Medical imaging apparatus for small animals, in a research laboratory environment

Filing History

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 8, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 8, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
May 5, 2026 SUPC
USE AMENDMENT FILED
Dec 19, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 19, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 21, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 21, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 15, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 19, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 19, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 19, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 19, 2025 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 13, 2025 GNFN
FINAL REFUSAL E-MAILED
Aug 13, 2025 GNFR
FINAL REFUSAL WRITTEN
Aug 13, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 2, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 25, 2024 MAFR
NEW APPLICATION ENTERED
Oct 25, 2024 NWAP